InfuSystem Holdings, Inc. reaffirmed earnings guidance for the full year 2023. For the period, the company expected net revenue growth estimated to be in the range of 8% to 10%, or approximately $118 million to $121 million in net revenues.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.36 USD | -3.78% |
|
-7.83% | -39.66% |
05-20 | InfuSystem Approves $20 Million Share Buyback Plan -- Shares Rise After Hours | MT |
05-20 | Tranche Update on InfuSystem Holdings, Inc.'s Equity Buyback Plan announced on June 30, 2021. | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.66% | 135M | |
-6.01% | 180B | |
-2.95% | 105B | |
-4.54% | 67.27B | |
-6.09% | 46.34B | |
+14.28% | 46.22B | |
+4.14% | 40.1B | |
+19.36% | 30.92B | |
+12.05% | 24.22B | |
-4.56% | 24.48B |
- Stock Market
- Equities
- INFU Stock
- News InfuSystem Holdings, Inc.
- InfuSystem Holdings, Inc. Reaffirms Earnings Guidance for the Full Year 2023